Comparison of SCH 39304 and its isomers, RR 42427 and SS 42426, for treatment of murine cryptococcal and coccidioidal meningitis.
SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives. In this study, we compared the efficacy of 304 with that of 426 and 427 in murine models of cryptococcal and coccidioidal meningitis. On day 18 postinfection with Cryptococcus neoformans, controls showed 80% mortality. The 50% protective doses calculated at this day were 0.56 mg of 304 per kg of body weight, 23.5 mg of 426 per kg, and 0.11 mg of 427 per kg. Controls with coccidioidal meningitis all succumbed, and treated mice at the same time point showed 50% protective doses of 10.8 mg/kg for 304, 200 mg/kg for 426, and 2.1 mg/kg for 427. We conclude that isomer 427 is five times as potent, whereas 426 is 1/50th as potent as 304 in these experimental mycoses.
Allendoerfer
R
R
Department of Medicine, University of Texas Health Science Center, San Antonio.
Yates
R R
RR
Marquis
A J
AJ
Loebenberg
D
D
Rinaldi
M G
MG
Graybill
J R
JR
D000284:Administration, Oral; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D001393:Azoles / Q000097:blood; D003045:Coccidioides / Q000187:drug effects; D003047:Coccidioidomycosis / Q000188:drug therapy* / Q000401:mortality; D003455:Cryptococcus neoformans / Q000187:drug effects; D046508:Culture Techniques; D007536:Isomerism; D016919:Meningitis, Cryptococcal / Q000188:drug therapy* / Q000401:mortality; D051379:Mice; D014230:Triazoles / Q000627:therapeutic use*
D000935:Antifungal Agents; D001393:Azoles; D014230:Triazoles; C056513:Sch 39304